Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday ...

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...

Shardul Nautiyal, Mumbai Tuesday, March 17, 2026, 08:00 Hrs [IST] ...

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...

The MarketWatch News Department was not involved in the creation of this content.-- New research advances genetic diagnosis -- Demonstrates the potential to expand equitable acces ...

New Zealanders with cancer and rare disorders will benefit from faster, locally delivered genomic testing through a new ...

CLEVELAND, March 10, 2026 /PRNewswire/ -- GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and ...

New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

PhD, FACMG has been elected President of the ACMG Foundation for Genetic and Genomic Medicine. The ACMG Foundation works to advance American College of Medical Genetics and Genomics (ACMG) educational ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the commercial launch ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.